⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3674559 | 1.00 | — | — | |
| SCHEMBL13840523 | 1.00 | — | — | |
| SCHEMBL8471281 | 1.00 | — | — | |
| SCHEMBL5868370 | 0.79 | ALDH1A1 (0.39) | — | |
| SCHEMBL5868371 | 0.79 | ALDH1A1 (0.39) | — | |
| SCHEMBL1783898 | 0.77 | — | — | |
| SCHEMBL1783896 | 0.77 | — | — | |
| SCHEMBL9254533 | 0.73 | — | — | |
| SCHEMBL9261865 | 0.73 | — | — | |
| SCHEMBL9014125 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210161847-A1 | METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION | OTT DAVID MICHAEL (US) | 2021-06-03 | — | — | US | disclosed |
| US-10940129-B2 | Method of treatment for reducing pain sensitization | OTT DAVID MICHAEL (US) | 2021-03-09 | — | — | US | disclosed |
| US-20200061008-A1 | METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION | OTT DAVID MICHAEL (US) | 2020-02-27 | — | — | US | disclosed |
| US-20170174623-A1 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Allium Vitalis, Inc. | 2017-06-22 | — | — | US | disclosed |
| US-20170100349-A1 | ORGANOSULFUR COMPOUNDS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | OTT DAVID MICHAEL (US) | 2017-04-13 | — | — | US | disclosed |
| US-9562007-B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | ALLIUM VITALIS INC. (US) | 2017-02-07 | — | — | US | disclosed |
| US-9456999-B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Allium Vitalis, Inc. (US) | 2016-10-04 | — | — | US | disclosed |
| US-20130165515-A1 | Organosulfur Compounds for the Prevention and Treatment of Neurodegenerative Diseases | ALLIUM VITALIS INC. | 2013-06-27 | — | — | US | disclosed |
| US-20130143967-A1 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | ALLIUM VITALIS INC. | 2013-06-06 | — | — | US | disclosed |
| US-20120197022-A1 | PROCESS FOR THE RESOLUTION OF (R,S)-NICOTINE | DIVI'S LABORATORIES LIMITED (IN) | 2012-08-02 | — | — | US | disclosed |
| WO-2004074517-A1 | METHODS FOR VARIATION DETECTION | NIKAGEN BIOTECHNOLOGIES LTD. (IL) | 2004-09-02 | — | — | WO | disclosed |
| US-20040166493-A1 | Methods for variation detection | PORAT, NOGA (IL) | 2004-08-26 | — | — | US | disclosed |
| US-20040132054-A1 | Method for the selective combinatorial randomization of polynucleotides | DIREVO BIOTECH AG (DE) | 2004-07-08 | — | — | US | disclosed |
| EP-1419248-A1 | METHOD FOR THE SELECTIVE COMBINATORIAL RANDOMIZATION OF POLYNUCLEOTIDES | Direvo Biotech AG (DE) | 2004-05-19 | — | — | EP | disclosed |
| WO-2004018674-A1 | METHOD FOR THE SELECTIVE COMBINATORIAL RANDOMIZATION OF POLYNUCLEOTIDES | DIREVO BIOTECH AG (DE) | 2004-03-04 | — | — | WO | disclosed |
| EP-1394251-A1 | Method for the selective randomization of polynucleotides | Direvo Biotech AG (DE) | 2004-03-03 | — | — | EP | disclosed |
| US-20040023220-A1 | Integrated method for PCR cleanup and oligonucleotide removal | APPLIED BIOSYSTEMS, LLC | 2004-02-05 | — | — | US | disclosed |
| WO-2004009851-A2 | METHOD FOR PCR CLEANUP AND OLIGONUCLEOTIDE REMOVAL | APPLERA CORPORATION (US) | 2004-01-29 | — | — | WO | disclosed |
| US-20040018987-A1 | Redox therapy for tumors | HOFFMAN ARNOLD (IL) | 2004-01-29 | — | — | US | disclosed |
| EP-0060659-A1 | Pharmaceutical composition for tumour treatment and process for preparing it | NATIONAL FOUNDATION FOR CANCER RESEARCH, INC. (US) | 1982-09-22 | — | — | EP | disclosed |